Safety, Tolerability, and Pharmacokinetics of the Novel Anti-Influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings
Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-018-0710-9
Full Text
Open PDFAbstract
Available in full text
Date
October 4, 2018
Authors
Publisher
Springer Science and Business Media LLC